Tracheal aspirate gene expression in preterm newborns and development of bronchopulmonary dysplasia

Pediatrics International

Volumn 54, Issue 2, 2012, Pages 208-214

  Hikino, Shunji ^a   Ohga, Shouichi ^a,b   Kinjo, Tadamune ^a   Kusuda, Takeshi ^a   Ochiai, Masayuki ^a   Inoue, Hirosuke ^a   Honjo, Satoshi ^c   Ihara, Kenji ^a   Ohshima, Koichi ^d   Hara, Toshiro ^a  

^a Department of Pediatrics ^*  (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA NATIONAL HOSPITAL   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

bronchopulmonary dysplasia; interleukin 10; platelet derived growth factor B; preterm infant; tracheal aspirate fluid cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASSISTED VENTILATION; CHORIOAMNIONITIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC RISK; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUNG DYSPLASIA; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; SENSITIVITY AND SPECIFICITY; TRACHEAL ASPIRATION PROCEDURE;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CYTOKINES; EXUDATES AND TRANSUDATES; FEMALE; GENE EXPRESSION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MULTIVARIATE ANALYSIS; NEUTROPHILS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-SIS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TRACHEA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84859909043     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2011.03510.x     Document Type: Article

References (28)

1. Kinsella JP, Greenough A, Abman SH,. Bronchopulmonary dysplasia. Lancet 2006; 367 (9520): 1421-31.
2. Ehrenkranz RA, Walsh MC, Vohr BR, et al,. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-60.
3. Groves AM, Briggs KA, Kuschel CA, Harding JE,. Predictors of chronic lung disease in the "CPAP era". J. Paediatr. Child Health 2004; 40: 290-94.
4. Kramer BW, Kallapur S, Newnham J, Jobe AH,. Prenatal inflammation and lung development. Semin. Fetal Neonatal Med. 2009; 14: 2-7.
5. Abman SH, Mourani PM, Sontag M,. Bronchopulmonary dysplasia: A genetic disease. Pediatrics 2008; 122: 658-9.
6. Bose CL, Dammann CE, Laughon MM,. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch. Dis. Child. Fetal Neonatal Ed. 2008; 93: F455-61.
7. Ryan RM, Ahmed Q, Lakshminrusimha S,. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin. Rev. Allergy Immunol. 2008; 34: 174-90.
8. Ambalavanan N, Carlo WA, D'Angio CT, et al,. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123: 1132-41.
9. Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW,. Increase of interleukin-6 in tracheal aspirate at birth: A predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr. 2006; 95: 38-43.
10. Paananen R, Husa AK, Vuolteenaho R, Herva R, Kaukola T, Hallman M,. Blood cytokines during the perinatal period in very preterm infants: Relationship of inflammatory response and bronchopulmonary dysplasia. J. Pediatr. 2009; 154: 39-43.
11. Watterberg K, Demers L, Scott S, Murphy S,. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-15.
12. Jonsson B, Tullus K, Bruner A, Lu Y, Noack G,. Early increase of TNFα and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 1997; 77: F198-201.
13. Jõnsson B, Li YH, Noack G, Brauner A, Tullus K,. Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr. 2000; 89: 1375-80.
14. McGowan EC, Kostadinov S, McLean K, et al,. Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk. Pediatr. Res. 2009; 66: 455-60.
15. Vicencio AG, Lee CG, Cho SJ, et al,. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: A new model for bronchopulmonary dysplasia? Am. J. Respir. Cell Mol. Biol. 2004; 31: 650-56.
16. Adcock KG, Martin J, Loggins J, Kruger TE, Baier RJ,. Elevated platelet-derived growth factor-BB concentrations in premature neonates who develop chronic lung disease. BMC Pediatr. 2004; 4: 10-20.
17. Ziesche R, Hofbauer E, Wittmann K, Petkov C, Block LH,. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 1999; 341: 1264-9.
18. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nakayama H, Hara T,. High expression of platelet-derived growth factor and transforming growth factor-β1 in blast cells from patients with Down syndrome suffering from transient myeloproliferative disorder and organ fibrosis. Br. J. Haematol. 2001; 115: 472-5.
19. Ohga S, Nomura A, Takada H, et al,. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J. Infect. Dis. 2001; 183: 1-7.
20. Bergeron A, Soler P, Kambouchner M, et al,. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10. Eur. Respir. J. 2003; 22: 69-76.
21. Munshi UK, Niu JO, Siddiq MM, Parton LA,. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr. Pulmonol. 1997; 24: 331-6.
22. Kazzi SNJ, Romero R, McLaughlin K, Ager J, Janisse J,. Serial changes in levels of IL-6 and IL-1β in premature infants at risk for bronchopulmonary dysplasia. Pediatr. Pulmonol. 2001; 31: 220-26.
23. McColm JR, Stenson BJ, Biermasz N, McIntosh N,. Measurement of interleukin-10 in bronchoalveolar lavage from preterm ventilated infants. Arch. Dis. Child. Fetal Neontal Ed. 2000; 82: 156-9.
24. Jones CA, Cayabyab RG, Kwong KY, et al,. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr. Res. 1996; 39: 966-7.
25. Davidson D, Miskolci V, Clark DC, Dolmaian G, Vancurova I,. Interleukin-10 production after pro-inflammatory stimulation of neutrophils and monocytic cells of the newborn. Comparison to exogenous interleukin-10 and dexamethasone levels needed to inhibit chemokine release. Neonatology 2007; 92: 127-33.
26. Garingo A, Tesoriero L, Cayabyab R, et al,. Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr. Res. 2007; 61: 197-202.
27. Paul DA, Zook K, Mackley A, Locke RG,. Reduced mortality and increased BPD with histological chorioamnionitis and leukocytosis in very-low-birth-weight infants. J. Perinatol. 2010; 30: 58-62.
28. Currie AE, Kelly M, Vyas JR, Pandya H, Field D, Kotecha S,. Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity. Arch. Dis. Child. Fetal Neonatal Ed. 2002; 86: F193-7.